Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lung Neoplasms × Standard of Care × Clear all

Status

Sponsor Class

Study Type

Interventional 31 Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 5 Breast Neoplasms 5 Neoplasms 4 Multiple Myeloma 4 Neoplasms, Plasma Cell 3 Hematologic Neoplasms 2 Frailty 2 Colorectal Neoplasms 2 Upper Excretory Tract Tumors 1 Transfusion-Related Acute Lung Injury 1 Thrombosis 1 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Sleep Disorders, Circadian Rhythm 1 Sezary Syndrome 1 Sarcopenia 1 Sarcoglycanopathies 1 Psoriasis 1 Peripheral Arterial Disease 1 Patient Acceptance of Health Care 1 Ovarian Neoplasms 1 Myocardial Infarction 1 Myeloproliferative Disorders 1 Mycoses 1 Melanoma 1 Malnutrition 1 Lymphoma 1 Lupus Erythematosus, Systemic 1 Lung Neoplasms 1 Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion 1

Interventions

Surveys and Questionnaires 19 Blood Specimen Collection 18 Gene Expression Profiling 12 Radiotherapy 11 Magnetic Resonance Spectroscopy 9 Surgical Procedures, Operative 8 Specimen Handling 8 Immunohistochemistry 8 Polymerase Chain Reaction 7 Drug Therapy 7 pembrolizumab 6 Observation 6 Amplified Fragment Length Polymorphism Analysis 6 Tomography, X-Ray Computed 5 Reverse Transcriptase Polymerase Chain Reaction 5 Psychiatric Rehabilitation 5 Liquid Biopsy 5 Interviews as Topic 5 Carboplatin 5 Bronchoscopy 5 Thoracic Surgery, Video-Assisted 4 Therapeutics 4 Paclitaxel 4 Microarray Analysis 4 Ipilimumab 4 Biopsy 4 Bevacizumab 4 osimertinib 3 durvalumab 3 atezolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03137264 2019-11-07

RADIANCE

AstraZeneca

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡